全球定序仪市场：2023-2028

本报告调查了全球定序仪市场，并提供了市场趋势以及截至2023年的历史资料和截至2028年的预测资料。还全面介绍了进入市场的公司的概况。

目录

第1章 执行摘要

第2章 市场发展及趋势

• 定序仪市场稳定，但也有变化的迹象
• 主要供应商的定序器系统和效能
• 特价讯息
• 趋势
• 临床应用
• 液体切片、循环核酸
• 监管和标准化工作
• 透过去中心化改善存取
• 竞争加剧的可能性
• NGS 技术的进步
• 长读取序列
• 单细胞定序
• 表观遗传定序
• 高通量定序
• 即时序列
• 携带式定序设备
• 直接RNA定序
• 空间转录组学
• 宏基因体学、微生物组
• 多组学整合

第3章 市场分析

• 摘要
• 依产品类型划分的定序仪市场
• 定序仪市场，依国家划分
• 市占率

第4章 公司简介

• 10X Genomics
• Agilent Technologies
• BGI (Beijing Genomics Inst.)
• 产前检测
• 测试服务
• 全基因组定序（WGS）
• NGS 定序
• 合作
• Berry Genomics
• CareDx
• CareDx 提供的检查服务
• CareDx 提供的产品
• 元素生物科学
• 精确的科学
• 近期营收和趋势
• Illumina
• 诊断
• 其他合作和公告
• 中国
• New England Biolabs
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• 背景和其他讯息
• Qiagen
• 液态生检
• Revvity
• 定序/基因组学
• 液体活检
• 产前业务
• 实验室服务
• Singular Genomic
• Takara Bio
• Tecan
• Thermo Fisher Scientific
• 次世代定序
• 移植医学
• 微生物组
• 其他合作和收购
• 基因编辑与细胞治疗
• Ultima Genomics

Kalorama Information's new comprehensive report, "Worldwide Sequencer Market, 2023-2028", provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process.

Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.

NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:

• Whole genome sequencing
• Targeted/amplicon resequencing
• Exome sequencing
• SNP analysis
• RNA sequencing
• Gene expression profiling
• Transcriptomics
• Small RNA/miRNA analysis
• ChIP-seq
• Methylation analysis
• Metagenomics

"Worldwide Sequencer Market, 2023-2028" provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.

Kalorama Information's new comprehensive report, Worldwide Sequencer Market, 2023-2028 , provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process."

Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.

NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:

• Whole genome sequencing
• Targeted/amplicon resequencing
• Exome sequencing
• SNP analysis
• RNA sequencing
• Gene expression profiling
• Transcriptomics
• Small RNA/miRNA analysis
• ChIP-seq
• Methylation analysis
• Metagenomics

Worldwide Sequencer Market, 2023-2028 provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.

Table of Contents

Chapter 1: Executive Summary

• Table 1-1: World Sequencer Market, 2023-2028 (in $ millions)
• Figure 1-1: World Sequencer Market, 2023-2028 (in $ millions)
• Figure 1-2: Annual Growth in World Sequencer Market, 2023-2028 (%)
• Table 1-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
• Figure 1-3: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
• Figure 1-4: World Sequencer Market Compound Annual Growth Rate (CAGR), by Product Segment, 2023-2028 (%)
• Table 1-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
• Figure 1-5: World Sequencer Market, Shares by Product Segment, 2023 (%)
• Figure 1-6: Cost of Sequencing a Human Genome, 2001-2023 (in $ millions)
• Current Trends
• Scope and Methodology
• Report Structure

Chapter 2: Market Development and Trends

• Sequencer Market Stable But Poised for Changes
• Major Vendors' Sequencer Systems and Performance
  • Table 2-1: Selected Short-Read Sequencer Systems' Performance, 2024
  • Table 2-2: Selected Long-Read Sequencer Systems' Performance, 2024
• Deals
  • Table 2-3: Deals in Sequencer Market, January 2020-July 2024
• Trends
• Clinical Applications
• Liquid Biopsy, Circulating Nucleic Acids
• Regulatory and Standardization Efforts
• Increased Access Through Decentralization
• Potential for Increasing Competition
• Advancements in NGS Technology
• Long-Read Sequencing
• Single Cell Sequencing
• Epigenetic Sequencing
• High-Throughput Sequencing
• Real-time Sequencing
• Portable Sequencing Devices
• Direct RNA Sequencing
• Spatial Transcriptomics
• Metagenomics, Microbiome
• Multi-Omics Integration

Chapter 3: Market Analysis

• Overview
  • Table 3-1: World Sequencer Market, 2023-2028 (in $ millions)
  • Figure 3-1: World Sequencer Market, 2023-2028 (in $ millions)
  • Figure 3-2: Illumina Revenue Annual Growth Rate, 2010-2023 (%)
  • Figure 3-3: Illumina Revenue Growth Rate 4-Year Moving Average, 2014-2023 (in $ millions)
• Sequencer Market by Product Types
  • Table 3-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
  • Table 3-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
  • Figure 3-4: World Sequencer Market, Share by Product Segment, 2023 (%)
  • Figure 3-5: World Sequencer Market, Share by Product Segment, 2028 (%)
• Sequencer Market by Country and Region
  • Table 3-4: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
  • Figure 3-6: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
  • Figure 3-7: Geographic Breakout of the World Sequencer Market, Share by Country/Region (APAC, Europe, North America, Rest of World), 2023 (%)
• Market Shares
  • Figure 3-8: World Sequencer Market, by Estimated Market Shares, by Company (Agilent, Illumina, MGI Tech, MilliporeSigma, Oxford Nanopore, Pacific Biosciences, Qiagen, Roche, Thermo Fisher, Other), 2023 (%)

Chapter 4: Company Profiles

• 10X Genomics
• Agilent Technologies
• BGI (Beijing Genomics Inst.)
• Prenatal Testing
• Test Services
• Whole Genome Sequencing (WGS)
• NGS Sequencing
• Collaborations
• Berry Genomics
• CareDx
  • Figure 4-1: CareDx Revenue, 2017-Q1 2024 (in $ millions)
• Testing Services Offered by CareDx
  • AlloMap Tests
  • AlloSure Tests
• Products Offered by CareDx
• Element Biosciences
• Exact Sciences
• Recent Revenues and Developments
• Illumina
  • Table 4-1: Illumina's Revenue History, 2015-2023 (in $ millions)
  • Figure 4-2: Illumina's Revenue History, 2017-Q1 2024 (in $ millions)
• Diagnostics
• Other Collaborations and Announcements
• China
• New England Biolabs
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• Background and Other Announcements
• Qiagen
• Liquid Biopsy
• Revvity
• Sequencing/Genomics
• Liquid Biopsy
• Prenatal Business
• Lab Services
• Singular Genomic
• Takara Bio
• Tecan
• Thermo Fisher Scientific
• Next-Generation Sequencing
• Transplant Medicine
• Microbiome
• Other Collaborations and Acquisitions
• Gene Editing and Cell Therapy
• Ultima Genomics